Evidence map›Paper›PMID 37084165›Full record

SynthesisWorld journal of pediatrics : WJP2023

Biomarkers of hypoxic-ischemic encephalopathy: a systematic review.

Inês Caramelo, Margarida Coelho, Miguel Rosado, Carla M P Cardoso, Alexandra Dinis, Carlos B Duarte, Mário Grãos, Bruno Manadas

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in World journal of pediatrics : WJP, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
27.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Inês Caramelo *CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
Margarida Coelho *CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
Miguel RosadoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
Carla M P CardosoStemlab SA, 3060-197, Cantanhede, Portugal.
Alexandra DinisPediatric Intensive Care Unit, Hospital Pediátrico, Centro Hospitalar E Universitário de Coimbra, 3000-075, Coimbra, Portugal.
Carlos B DuarteCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
Mário GrãosBiocant, Technology Transfer Association, 3060-197, Cantanhede, Portugal.
Bruno ManadasCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal. bmanadas@cnc.uc.pt.ORCID http://orcid.org/0000-0002-2087-4042
University of Coimbra · PTBiocant · PTHospitais da Universidade de Coimbra · PT

Funding

Fundação para a Ciência e Tecnologia - Portugal 2020.07749.BDFundação para a Ciência e Tecnologia - Portugal PD/BD/135178/2017Fundação para a Ciência e Tecnologia - Portugal POCI-01-0145-FEDER-029311Fundação para a Ciência e Tecnologia - Portugal POCI-01-0247-FEDER-045311Fundação para a Ciência e Tecnologia - Portugal SFRH/BD/143442/2019Fundação para a Ciência e Tecnologia - Portugal UIDB/04539/2020Fundação para a Ciência e Tecnologia - Portugal UIDP/04539/2020
6 · The paper itself

Abstract

backgroundCurrent diagnostic criteria for hypoxic-ischemic encephalopathy in the early hours lack objective measurement tools. Therefore, this systematic review aims to identify putative molecules that can be used in diagnosis in daily clinical practice (PROSPERO ID: CRD42021272610). DATA SOURCES: Searches were performed in PubMed, Web of Science, and Science Direct databases until November 2020. English original papers analyzing samples from newborns > 36 weeks that met at least two American College of Obstetricians and Gynecologists diagnostic criteria and/or imaging evidence of cerebral damage were included. Bias was assessed by the Newcastle-Ottawa Scale. The search and data extraction were verified by two authors separately.

resultsFrom 373 papers, 30 met the inclusion criteria. Data from samples collected in the first 72 hours were extracted, and increased serum levels of neuron-specific enolase and S100-calcium-binding protein-B were associated with a worse prognosis in newborns that suffered an episode of perinatal asphyxia. In addition, the levels of glial fibrillary acidic protein, ubiquitin carboxyl terminal hydrolase isozyme-L1, glutamic pyruvic transaminase-2, lactate, and glucose were elevated in newborns diagnosed with hypoxic-ischemic encephalopathy. Moreover, pathway analysis revealed insulin-like growth factor signaling and alanine, aspartate and glutamate metabolism to be involved in the early molecular response to insult.

conclusionsNeuron-specific enolase and S100-calcium-binding protein-B are potential biomarkers, since they are correlated with an unfavorable outcome of hypoxic-ischemic encephalopathy newborns. However, more studies are required to determine the sensitivity and specificity of this approach to be validated for clinical practice.

Indexed as

Asphyxia NeonatorumHypoxia-Ischemia, BrainBiomarkersFemaleHumansInfant, NewbornPhosphopyruvate HydratasePregnancyPrognosisS100 ProteinsBiomarkersPhosphopyruvate HydrataseS100 ProteinsBiomarkerHypoxic–ischemic encephalopathyNeonatal brain injuryNeuron-specific enolaseNewbornS100-calcium-binding protein-B

Identifiers

PMID37084165
PMCPMC10199106
OpenAlexW4366603377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.